FRBRX
FSS FR Bio-Tech Discovery Cl R6
$203.35
FSS FR Bio-Tech Discovery Cl R6 (FRBRX)
FRBRX is a mutual fund that focuses on investing in the biotechnology sector. It aims to discover and capitalize on emerging companies in the field of biotechnology, which involves the use of living organisms and biological systems to develop new products and technologies. This fund is classified as Class R6, which typically indicates a fund with lower expenses and higher minimum investment requirements. With its ticker symbol FRBRX, this mutual fund offers investors the opportunity to potentially benefit from the growth and innovation in the biotech industry.
FRBRX Mutual Fund Chart & Stats
$203.35
At close: 4:00 PM EST- Previous Close
- $203.35
- Sub-Category
- Sector-Specific
- Total Liabilities
- $37.83M
- Expense Ratio
- 0.67%
- Holding Count
- 108
- Brand
- Franklin Strategic Series
- Category
- Equity
- Total Assets
- 1.19B
- Shares Outstanding
- N/A
- 52-Week Range
- $173.67 - $231.92
FRBRX Mutual Fund News
FRBRX Mutual Fund Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| JAZZJazz Pharmaceuticals | 5.66% |
| AMGNAmgen Inc | 4.39% |
| GILDGilead Sciences | 3.86% |
| REGNRegeneron Pharmaceuticals | 3.77% |
| ARGXArgenx | 3.62% |
| VRTXVertex Pharmaceuticals Inc. | 3.54% |
| USD_CASHFranklin Institutional U.S. Government Money Market Fund | 3.18% |
| RVMDRevolution Medicines, Inc. | 3.01% |
| GHGuardant Health | 2.76% |
| ASNDAscendis Pharma A/S | 2.56% |
| Total | 36.34% |
Recently Viewed
No data currently available






